M
Milan Milojevic
Researcher at Cardiovascular Institute of the South
Publications - 90
Citations - 5478
Milan Milojevic is an academic researcher from Cardiovascular Institute of the South. The author has contributed to research in topics: Percutaneous coronary intervention & Medicine. The author has an hindex of 20, co-authored 69 publications receiving 2148 citations. Previous affiliations of Milan Milojevic include Erasmus University Medical Center & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients
Roberto Lorusso,Glenn J.R. Whitman,Milan Milojevic,Milan Milojevic,Giuseppe Maria Raffa,David M. McMullan,Udo Boeken,Jonathan W. Haft,Christian A. Bermudez,Ashish S. Shah,David A. D'Alessandro +10 more
TL;DR: A concise, comprehensive and relevant analysis of all aspects related to PC-ECLS, with a particular emphasis on indications, technique, management and avoidance of complications, appraisal of new approaches and ethics, education and training is created.
Journal ArticleDOI
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study
Kuniaki Takahashi,Patrick W. Serruys,Chao Gao,Masafumi Ono,Rutao Wang,Daniel J F M Thuijs,Michael J. Mack,Nick Curzen,Friedrich-Wilhelm Mohr,Piroze M. Davierwala,Milan Milojevic,Milan Milojevic,Joanna J. Wykrzykowska,Joanna J. Wykrzykowska,Robbert J. de Winter,Faisal Sharif,Yoshinobu Onuma,Stuart J. Head,Arie Pieter Kappetein,Marie-Claude Morice,David R. Holmes,Syntax Extended Survival Investigators +21 more
TL;DR: In this article, the authors investigated 10-year all-cause death according to incomplete (IR) versus complete revascularization (CR) in patients with 3-vessel disease and left main coronary art...
Journal ArticleDOI
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Hideyuki Kawashima,Patrick W. Serruys,Patrick W. Serruys,Masafumi Ono,Hironori Hara,Neil O'Leary,Michael J. Mack,David R. Holmes,Marie-Claude Morice,Stuart J. Head,Arie Pieter Kappetein,Daniel J F M Thuijs,Milan Milojevic,Thilo Noack,Friedrich-Wilhelm Mohr,Piroze M. Davierwala,Faisal Sharif,John W. McEvoy,Yoshinobu Onuma,Syntax Extended Survival Investigators +19 more
TL;DR: In this paper, the benefit of optimal medical therapy (OMT) on 5-year outcomes in patients with 3-vessel disease and/or left main disease after percutaneous coronary intervention or coronary artery bypass grafting (CABG) was demonstrated in the randomized SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial.
Journal ArticleDOI
2020 EACTS/ELSO/STS/AATS Expert Consensus on Post-Cardiotomy Extracorporeal Life Support in Adult Patients
Roberto Lorusso,Glenn J.R. Whitman,Milan Milojevic,Milan Milojevic,Giuseppe Maria Raffa,David M. McMullan,Udo Boeken,Jonathan W. Haft,Christian A. Bermudez,Ashish S. Shah,David A. D'Alessandro +10 more
TL;DR: A concise, comprehensive and relevant analysis of all aspects related to PC-ECLS, with a particular emphasis on indications, technique, management and avoidance of complications, appraisal of new approaches and ethics, education and training is created.
Journal ArticleDOI
Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.
Daniel J F M Thuijs,Milan Milojevic,Gregg W. Stone,John D. Puskas,Patrick W. Serruys,Joseph F. Sabik,Ovidiu Dressler,Aaron Crowley,Stuart J. Head,A. Pieter Kappetein +9 more
TL;DR: To evaluate the impact of left ventricular ejection fraction (LVEF) on 3‐year outcomes in patients with left main coronary artery disease (LMCAD) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in the EXCEL trial.